1. Home
  2. CMRE vs NRIX Comparison

CMRE vs NRIX Comparison

Compare CMRE & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$13.94

Market Cap

1.9B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$24.12

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
NRIX
Founded
1974
2009
Country
Monaco
United States
Employees
1880
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CMRE
NRIX
Price
$13.94
$24.12
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$12.00
$30.50
AVG Volume (30 Days)
469.7K
3.2M
Earning Date
04-29-2026
04-08-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$48.05
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
99.31
52 Week Low
$9.03
$8.20
52 Week High
$18.06
$24.03

Technical Indicators

Market Signals
Indicator
CMRE
NRIX
Relative Strength Index (RSI) 27.88 84.48
Support Level $12.18 $14.86
Resistance Level $17.76 N/A
Average True Range (ATR) 0.53 1.42
MACD -0.15 0.81
Stochastic Oscillator 2.44 92.45

Price Performance

Historical Comparison
CMRE
NRIX

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: